Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer

Japanese Journal of Cancer Research

Volumn 92, Issue 1, 2001, Pages 51-58

  Matsumoto, M ^a   Takeda, Y ^a   Maki, H ^a   Hojo, K ^a   Wada, T ^a   Nishitani, Y ^a   Maekawa, R ^a   Yoshioka, T ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Combination chemotherapy; Gemcitabine; Lung cancer; Nedaplatin

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; NEDAPLATIN; PLATINUM COMPLEX; SODIUM CHLORIDE;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CELL COUNT; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER TRANSPLANTATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LUNG CANCER; MOUSE; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0035112636     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01047.x     Document Type: Article

References (35)

1. Synthesis of (glycolato-O,O′)diammineplatinum (II) and its related complexes
2. Effect of treatment schedule on antitumor activity of glycolato-O,O′ diammineplatinum (II), a new platinum derivative: Comparison with cis-diamminedichloroplatinum (II)
3. Anti-tumor activity of 254-S, a platinum complex, in rodents
4. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammine glycolatoplatinum (254-S) and cis-diammine dichloroplatinum
5. Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices
6. Phase II clinical study of (glycolato-O,O′)diammineplatinum (II), a new platinum complex, for primary lung cancer
7. Phase II study of (glycolato-O,O′)diammineplatinum (II), a novel platinum complex, in the treatment of non-small-cell lung cancer
8. An early phase II study of cisdiammine glycolato platinum, 254-S, for head and neck cancers
9. Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract
10. Phase II study of cis-diammine(glycolato)platinum (254-S), a new platinum complex, for gynecological malignancy
11. Augmented antitumor activity in combination chemotherapy of Nedaplatin with Etoposide
12. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts
13. Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model
14. Preclinical in vivo activity of 2′,2′-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer
15. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer
16. Gemcitabine. A cytidine analogue active against solid tumors
17. Phase II study of gemcitabine in advanced colorectal adenocarcinoma
18. Phase II trial of gemcitabine (2′,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
19. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: A phase II study
20. Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC)
21. Phase II study of gemcitabine (2′,2′-difluorode-oxycytidine) in previously treated ovarian cancer patients
22. Clinical experience with gemcitabine in pancreatic carcinoma
23. Synergistic interaction between cisplatin and gemcitabine in vitro
24. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
25. Phase I study of gemcitabine and cisplatin in non-small cell lung cancer: Semin
26. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study
27. Combination therapy with gemcitabine in non-small cell lung cancer
28. Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
29. Cisplatin and gemcitabine in non-small-cell lung cancer
30. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin-etoposide in the treatment of locally advanced or metastatic non-small-cell lung cancer
31. Gemcitabine and carboplatin: An update of Phase I and II studies in non-small cell lung cancer
32. Some statistical methods useful in circulation research
33. New tables for multiple comparisons with a control
34. Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts
35. Scheduling of gemcitabine and cisplatin in Lewis lung tumour bearing mice